Close Menu

NEW YORK (GenomeWeb) – Spanish molecular diagnostics firm Stat-Dx today said that it has secured a €20 million ($22.4 million) loan facility from the European Investment Bank for the development of diagnostic tools to identify infectious pathogens.

The loan will be drawn in two tranches over a three-year period with full repayment on the maturity date five years ahead. The funds will go toward the cofinancing of a three-year project "aimed at enabling faster and more accurate diagnostics that will replace current complex protocols to obtain analytical results," Stat-Dx said.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The first reported coronavirus cases in Europe and the US might not be related to the subsequent outbreaks in those areas, according to the New York Times.

According to NPR, there's a growing shortage of machines to run SARS-CoV-2 tests.

The Wall Street Journal and Kaiser Health News report that antibody testing for SARS-CoV-2 has led to further confusion.

In Nature this week: the largest known collection of human genetic variants, and more.